Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance

Chinese Medical Journal

Volumn 121, Issue 10, 2008, Pages 881-886

  Chen, Xiang Yu ^a   Li, Jian Sheng ^a   Liang, Qian Ping ^a   He, De Zhi ^a   Zhao, Jing ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Angiogenesis; Esophageal squamous cell carcinoma; Immunohistochemistry; PC cell derived growth factor; Vascular endothelial growth factor

Indexed keywords

ENDOGLIN; PROGRANULIN; VASCULOTROPIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CANCER INFILTRATION; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CLASSIFICATION; VASCULAR ENDOTHELIUM;

EID: 51149096388     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200805020-00004     Document Type: Article

References (31)

1. Li C, Liang YG, Wu MY, Xu LY, Cai WJ. Telomerase activity analysis of esophageal carcinoma using microdissection-TR AP assay. Chin Med J 2002; 115: 1405-1408.
2. Gun W, Wang N, Li Y, Zhang JH. Polymorphisms in tumor necrosis factor genes and susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma in a population of high incidence region of North China. Chin Med J 2005, 118: 1870-1878.
3. Wang QS. Liu L, Dong L, Shen ZL, Zhou DH, Hu CX. Laparoscopic Heller-Dor operation for patients with achalasia. Chin Med J 2006; 119: 443-447.
4. Pulukuri SM, Rao JS. Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis. Cancer Res 2007; 67: 6637-6646.
5. Gutierrez M, Giaccone G. Antiangiogecnic therapy in nonsmall cell lung cancer. Curr Opin Oncol 2008; 20: 176-182.
6. Cai SX. Small molecule vascular disrupting agents: potential new drugs for cancer treatment. Recent Patents Anticancer Drug Discov 2007; 2: 79-101.
7. Liang ZH, Wu PH, Li L, Xue G, Zeng YX, Huang WL. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein. Chin Med J 2004; 117: 1809-1814.
8. Jiang CQ, Fan LF, Liu ZS, Qian Q, Zia D, Diao LM, et al. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma. Chin Med J 2004; 117: 1541-1546.
9. Richter-Ehrenstein C, Rentzsch J, Runkel S, Schneider A, Schönfelder G. Endothelial progenitor cells in breast cancer patients. Breast Cancer Res Treat 2007: 106: 343-349.
10. Wang FH, Sun XD, Zhang X, Xu X, Zhu Q, Huang JN, et al. Role of pigment epithelium-derived factor on proliferation and migration of choroidal capillary endothelium induced by vascular endothelial growth factor in vitro. Chin Med J 2007; 120: 1534-1538.
11. Goncalves V, Gautier B, Coric P, Bouaziz S, Lenoir C, Garbay C, et al. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor. J Med Chem 2007; 50: 5135-5146.
12. Serrero G. Autocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesis. Biochem Biophys Res Commun 2003; 308: 409-413.
13. Serrero G. Ioffe OB. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium. Hum Pathol 2003; 34: 1148-1154.
14. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5835.
15. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. Natl Cancer Inst 1992; 84: 1875-1887.
16. Veeravagu A, Hsu AR, Cai W, Hou LC, Tse VC, Chen X. Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy. Recent Patents Anticancer Drug Discov 2007; 2: 59-71.
17. Jung HJ, Shim JS, Suh YG, Kim YM, Ono M, Kwon HJ. Potent inhibition of in vivo angiogenesis and tumor growth by a novel cyclooxygenase-2 inhibitor, enoic acanthoic acid. Cancer Sci 2007; 98: 1943-1949.
18. Koh H, Tasaka S, Hasegawa N, Yamada W, Shimizu M, Nakamura M, et al. Protective role of vascular endothelial growth factor in endotoxin-induced acute lung injury in mice. Respir Res 2007; 8: 60.
19. Zhou Z, Bolontrade MF, Reddy K, Duan X, Guan H, Yu L, et al. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy. Clin Cancer Res 2007; 13: 4867-4873.
20. Zhao JJ, Hu. JQ, Cai JQ, Yang XJ, Yang ZH. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Chin Med J 2003; 116: 772-776.
21. Zhou J, Gao G, Crabb JW, Serrero G. Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigeme cell line. J Biol Chem 1993; 268: 10863-10869.
22. He Z, Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 2003; 81: 600-612.
23. Xu SQ, Tang D, Chamberlain S, Pronk G, Masiafz FR, Kaur S. The granulin/ epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro. J Biol Chem 1998; 273: 20078-20083.
24. Jones MB, Michener CM, Blanchette JO, Kuznetsov VA, Raffeld M, Serrero G. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Clin Cancer Res 2003; 9: 44-51.
25. Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, et al. PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Clin Cancer Res 2004; 10: 1333-1337.
26. Kong WJ, Zhang SL, Chen X, Zhang S, Wang YJ, Zhang D. PC cell-derived growth factor overexpression promotes proliferation and survival of laryngeal carcinoma. Anticancer Drugs 2007; 18: 29-40.
27. He Z, Ismail A, Kriazhev L, Sadvakassova G, Bateman A. Progranulin (PC-cell-derived growth factor/acrogranin) regulates invasion and cell survival. Cancer Res 2002, 62: 5590-5596.
28. Pizarro GO. Zhou XC. Koch A. Gharib M. Raval S. Bible K. Prosurvival function of the granulin-epithelin precursor is important in tumor progression and chemoresponse. Int J Cancer 2007; 120: 2339-2343.
29. Monami G, Gonzalez EM, Hellman M, Gomella LG, Baffa R, lozzo RV. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/ FAK/ERK complex. Cancer Res 2006; 66: 7103-7110.
30. Tangkeangsirisin W, Serrero G. PC cell-derived growth factor (PCDGF/ GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. Carcinogenesis 2004; 25: 1587-1592.
31. Huang T, Song HP, Zhang JH. Human breast carcinoma cell line MCF-7 and expression of VEGF. Chin J Cancer (Chin) 2006; 25: 303-307.